<DOC>
	<DOCNO>NCT00833131</DOCNO>
	<brief_summary>The addition Oxaliplatin conventionally fractionate chemoradiation ( FULV capecitabine ) consider standard unresectable rectal cancer panel expert . The Investigators address question whether short-course preoperative radiotherapy consolidate chemotherapy FOLFOX4 may increase rate R0 resection patient unresectable rectal cancer .</brief_summary>
	<brief_title>The Randomised Study Preoperative Radiotherapy With Consolidating Chemotherapy Unresectable Rectal Cancer</brief_title>
	<detailed_description>Patients unresectable primary rectal cancer unresectable local recurrence without distant metastasis randomly allocate control experimental arm . The preoperative treatment control arm conventionally fractionate chemoradiation 50.4 Gy total dose 28 fraction 1.8 Gy 5.5 week simultaneously 5-Fu , leucovorin oxaliplatin . Experimental group receive 25 Gy 5 fraction 5 Gy 5 day one week interval - consolidate chemotherapy 3 course FOLFOX4 . Surgery curry 10-11 week begin radiation least 4 week last dose fluorouracil radiation . The study hypothesis short-course preoperative radiotherapy consolidate chemotherapy produce least 10 % increase rate R0 resection compare preoperative chemoradiation .</detailed_description>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<criteria>Patients unresectable primary rectal cancer unresectable local recurrence without distant metastasis . WHO performance status ≤ 2 . Lower border tumour ≤ 15 cm anal verge . cardiac coronary arterial disease , arrhythmia , stroke even occur past control medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2010</verification_date>
	<keyword>Rectal cancer</keyword>
	<keyword>Preoperative radiotherapy consolidate chemotherapy</keyword>
</DOC>